25 XP   0   0   10

Mayinglong Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Mayinglong together

PenkeI guess you are interested in Mayinglong Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mayinglong Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Mayinglong Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Mayinglong Pharmaceutical Group Co Ltd.

Quick analysis of Mayinglong (30 sec.)










What can you expect buying and holding a share of Mayinglong? (30 sec.)

How much money do you get?

How much money do you get?
¥0.05
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥8.98
Expected worth in 1 year
¥9.56
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
¥0.96
Return On Investment
3.7%

For what price can you sell your share?

Current Price per Share
¥25.99
Expected price per share
¥24.20 - ¥27.16
How sure are you?
50%

1. Valuation of Mayinglong (5 min.)




Live pricePrice per Share (EOD)

¥25.99

Intrinsic Value Per Share

¥18.36 - ¥67.47

Total Value Per Share

¥27.34 - ¥76.44

2. Growth of Mayinglong (5 min.)




Is Mayinglong growing?

Current yearPrevious yearGrowGrow %
How rich?$534.8m$485.6m$39.1m7.5%

How much money is Mayinglong making?

Current yearPrevious yearGrowGrow %
Making money$15.3m$16.5m-$1.2m-8.1%
Net Profit Margin13.7%13.4%--

How much money comes from the company's main activities?

3. Financial Health of Mayinglong (5 min.)




What can you expect buying and holding a share of Mayinglong? (5 min.)

Welcome investor! Mayinglong's management wants to use your money to grow the business. In return you get a share of Mayinglong.

What can you expect buying and holding a share of Mayinglong?

First you should know what it really means to hold a share of Mayinglong. And how you can make/lose money.

Speculation

The Price per Share of Mayinglong is ¥25.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mayinglong.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mayinglong, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥8.98. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.09 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mayinglong.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.0%0.040.1%0.040.1%0.030.1%0.030.1%
Usd Book Value Change Per Share0.010.0%0.020.1%0.020.1%0.030.1%0.020.1%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.0%0.010.0%
Usd Total Gains Per Share0.010.0%0.030.1%0.040.1%0.040.1%0.030.1%
Usd Price Per Share3.34-3.53-3.08-3.05-2.91-
Price to Earnings Ratio104.78-42.62-22.64-26.56-34.97-
Price-to-Total Gains Ratio375.93-44.84--15.65-122.35-96.34-
Price to Book Ratio2.69-2.91-2.74-3.02-3.73-
Price-to-Total Gains Ratio375.93-44.84--15.65-122.35-96.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.591818
Number of shares278
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.030.04
Gains per Quarter (278 shares)9.2310.64
Gains per Year (278 shares)36.9142.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1152227142933
2294564275876
344671014187119
4589013854116162
57311217568145205
68713421282174248
710215724995203291
8116179286109232334
9131201323122260377
10145224360136289420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%78.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%68.010.00.087.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%74.00.04.094.9%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%69.09.00.088.5%

Fundamentals of Mayinglong

About Mayinglong Pharmaceutical Group Co Ltd

Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. The company products pipeline primarily consists of functional cosmetics, functional care products, functional food, and Chinese herbal medicines, as well as hemorrhoid, gynecological, cough, and skin products; and medical instruments. It is also involved in the retail and wholesale of medical devices and drugs; provision of hospital medical services; and operation of hospitals. The company sells its products through online channels. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is headquartered in Wuhan, China.

Fundamental data was last updated by Penke on 2024-04-18 00:47:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Mayinglong Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mayinglong earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.6% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 3.6%. The company is making a profit. +1
  • The TTM is 13.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ3.6%TTM13.7%-10.1%
TTM13.7%YOY13.4%+0.3%
TTM13.7%5Y14.6%-0.9%
5Y14.6%10Y13.8%+0.8%
1.1.2. Return on Assets

Shows how efficient Mayinglong is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.5% Return on Assets means that Mayinglong generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.5%TTM2.2%-1.7%
TTM2.2%YOY2.6%-0.4%
TTM2.2%5Y2.7%-0.5%
5Y2.7%10Y2.5%+0.1%
1.1.3. Return on Equity

Shows how efficient Mayinglong is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.7% Return on Equity means Mayinglong generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 0.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM3.0%-2.4%
TTM3.0%YOY3.6%-0.5%
TTM3.0%5Y3.6%-0.6%
5Y3.6%10Y3.4%+0.2%

1.2. Operating Efficiency of Mayinglong Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mayinglong is operating .

  • Measures how much profit Mayinglong makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.5%-7.5%
TTM7.5%YOY13.7%-6.1%
TTM7.5%5Y13.8%-6.2%
5Y13.8%10Y7.7%+6.0%
1.2.2. Operating Ratio

Measures how efficient Mayinglong is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.64 means that the operating costs are ¥1.64 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 1.641. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.456. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.641TTM1.456+0.185
TTM1.456YOY1.423+0.033
TTM1.4565Y1.437+0.019
5Y1.43710Y1.065+0.371

1.3. Liquidity of Mayinglong Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mayinglong is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.54 means the company has ¥5.54 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 5.538. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.121. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.538TTM6.121-0.584
TTM6.121YOY4.930+1.191
TTM6.1215Y4.887+1.235
5Y4.88710Y2.817+2.070
1.3.2. Quick Ratio

Measures if Mayinglong is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.45 means the company can pay off ¥0.45 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 0.455. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.634. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.455TTM1.634-1.179
TTM1.634YOY1.377+0.257
TTM1.6345Y1.115+0.519
5Y1.11510Y1.237-0.122

1.4. Solvency of Mayinglong Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mayinglong assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mayinglong to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that Mayinglong assets are financed with 19.9% credit (debt) and the remaining percentage (100% - 19.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 0.199. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.240. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.199TTM0.240-0.041
TTM0.240YOY0.240-0.001
TTM0.2405Y0.227+0.013
5Y0.22710Y0.212+0.014
1.4.2. Debt to Equity Ratio

Measures if Mayinglong is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 25.7% means that company has ¥0.26 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The MRQ is 0.257. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.328. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.257TTM0.328-0.071
TTM0.328YOY0.332-0.004
TTM0.3285Y0.306+0.022
5Y0.30610Y0.284+0.022

2. Market Valuation of Mayinglong Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Mayinglong generates.

  • Above 15 is considered overpriced but always compare Mayinglong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 104.78 means the investor is paying ¥104.78 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The EOD is 112.618. Based on the earnings, the company is expensive. -2
  • The MRQ is 104.775. Based on the earnings, the company is expensive. -2
  • The TTM is 42.623. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD112.618MRQ104.775+7.843
MRQ104.775TTM42.623+62.153
TTM42.623YOY22.641+19.982
TTM42.6235Y26.563+16.060
5Y26.56310Y34.966-8.404
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The EOD is 7.104. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.610. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 38.340. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.104MRQ6.610+0.495
MRQ6.610TTM38.340-31.730
TTM38.340YOY25.916+12.424
TTM38.3405Y-64.196+102.535
5Y-64.19610Y-67.241+3.045
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mayinglong is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Mayinglong Pharmaceutical Group Co Ltd:

  • The EOD is 2.895. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.693. Based on the equity, the company is underpriced. +1
  • The TTM is 2.906. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.895MRQ2.693+0.202
MRQ2.693TTM2.906-0.213
TTM2.906YOY2.739+0.168
TTM2.9065Y3.023-0.117
5Y3.02310Y3.731-0.708
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Mayinglong Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0590.146-59%0.177-66%0.188-69%0.134-56%
Book Value Per Share--8.9788.808+2%8.152+10%7.326+23%5.959+51%
Current Ratio--5.5386.121-10%4.930+12%4.887+13%2.817+97%
Debt To Asset Ratio--0.1990.240-17%0.240-17%0.227-12%0.212-6%
Debt To Equity Ratio--0.2570.328-22%0.332-23%0.306-16%0.284-9%
Dividend Per Share--0.0050.095-95%0.095-95%0.089-94%0.075-93%
Eps--0.0580.257-78%0.278-79%0.250-77%0.193-70%
Free Cash Flow Per Share--0.9150.206+343%0.155+491%0.213+330%0.205+347%
Free Cash Flow To Equity Per Share--0.9150.197+365%0.261+250%0.207+341%0.202+353%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--67.466--------
Intrinsic Value_10Y_min--18.358--------
Intrinsic Value_1Y_max--1.745--------
Intrinsic Value_1Y_min--0.999--------
Intrinsic Value_3Y_max--9.065--------
Intrinsic Value_3Y_min--3.747--------
Intrinsic Value_5Y_max--20.994--------
Intrinsic Value_5Y_min--7.292--------
Market Cap11203093875.840+7%10422886106.88011017740648.960-5%9612504556.800+8%9567764685.024+9%9112388857.984+14%
Net Profit Margin--0.0360.137-74%0.134-73%0.146-75%0.138-74%
Operating Margin---0.075-100%0.137-100%0.138-100%0.077-100%
Operating Ratio--1.6411.456+13%1.423+15%1.437+14%1.065+54%
Pb Ratio2.895+7%2.6932.906-7%2.739-2%3.023-11%3.731-28%
Pe Ratio112.618+7%104.77542.623+146%22.641+363%26.563+294%34.966+200%
Price Per Share25.990+7%24.18025.560-5%22.300+8%22.078+10%21.047+15%
Price To Free Cash Flow Ratio7.104+7%6.61038.340-83%25.916-74%-64.196+1071%-67.241+1117%
Price To Total Gains Ratio404.073+7%375.93244.836+738%-15.646+104%122.352+207%96.343+290%
Quick Ratio--0.4551.634-72%1.377-67%1.115-59%1.237-63%
Return On Assets--0.0050.022-77%0.026-80%0.027-81%0.025-80%
Return On Equity--0.0070.030-78%0.036-81%0.036-81%0.034-80%
Total Gains Per Share--0.0640.240-73%0.272-76%0.277-77%0.209-69%
Usd Book Value--534820959.185524731129.786+2%485630949.418+10%438760493.717+22%356871431.832+50%
Usd Book Value Change Per Share--0.0080.020-59%0.024-66%0.026-69%0.018-56%
Usd Book Value Per Share--1.2411.217+2%1.127+10%1.012+23%0.824+51%
Usd Dividend Per Share--0.0010.013-95%0.013-95%0.012-94%0.010-93%
Usd Eps--0.0080.036-78%0.038-79%0.035-77%0.027-70%
Usd Free Cash Flow--54482542.92712289482.291+343%9219384.942+491%12696587.112+329%11045861.161+393%
Usd Free Cash Flow Per Share--0.1260.029+343%0.021+491%0.029+330%0.028+347%
Usd Free Cash Flow To Equity Per Share--0.1260.027+365%0.036+250%0.029+341%0.028+353%
Usd Market Cap1548267573.641+7%1440442859.9711522651757.686-5%1328448129.750+8%1322265079.470+9%1259332140.173+14%
Usd Price Per Share3.592+7%3.3423.532-5%3.082+8%3.051+10%2.909+15%
Usd Profit--3436977.68515314319.815-78%16549611.630-79%14966179.582-77%11529713.944-70%
Usd Revenue--95427364.981108374588.380-12%122043695.744-22%107458604.682-11%86402974.263+10%
Usd Total Gains Per Share--0.0090.033-73%0.038-76%0.038-77%0.029-69%
 EOD+4 -4MRQTTM+14 -21YOY+17 -185Y+16 -1910Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Mayinglong Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15112.618
Price to Book Ratio (EOD)Between0-12.895
Net Profit Margin (MRQ)Greater than00.036
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.455
Current Ratio (MRQ)Greater than15.538
Debt to Asset Ratio (MRQ)Less than10.199
Debt to Equity Ratio (MRQ)Less than10.257
Return on Equity (MRQ)Greater than0.150.007
Return on Assets (MRQ)Greater than0.050.005
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Mayinglong Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.995
Ma 20Greater thanMa 5023.599
Ma 50Greater thanMa 10023.248
Ma 100Greater thanMa 20023.606
OpenGreater thanClose25.630
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Operating Income  63,549113,289176,838-87,07389,76565,147154,912-160,241-5,329
Tax Provision  12,04626,46038,506-25,03313,47210,15523,628-26,369-2,742



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,829,524
Total Liabilities959,618
Total Stockholder Equity3,737,968
 As reported
Total Liabilities 959,618
Total Stockholder Equity+ 3,737,968
Total Assets = 4,829,524

Assets

Total Assets4,829,524
Total Current Assets3,771,578
Long-term Assets1,057,945
Total Current Assets
Cash And Cash Equivalents 2,988,096
Short-term Investments 63,285
Net Receivables 246,373
Inventory 273,477
Other Current Assets 33,140
Total Current Assets  (as reported)3,771,578
Total Current Assets  (calculated)3,604,372
+/- 167,207
Long-term Assets
Property Plant Equipment 635,528
Goodwill 25,263
Intangible Assets 161,774
Long-term Assets Other 22,459
Long-term Assets  (as reported)1,057,945
Long-term Assets  (calculated)845,024
+/- 212,921

Liabilities & Shareholders' Equity

Total Current Liabilities681,071
Long-term Liabilities278,547
Total Stockholder Equity3,737,968
Total Current Liabilities
Short Long Term Debt 45,800
Accounts payable 289,686
Other Current Liabilities 20,225
Total Current Liabilities  (as reported)681,071
Total Current Liabilities  (calculated)355,711
+/- 325,360
Long-term Liabilities
Long term Debt 100,000
Capital Lease Obligations Min Short Term Debt93,587
Long-term Liabilities Other 28,459
Long-term Liabilities  (as reported)278,547
Long-term Liabilities  (calculated)222,045
+/- 56,501
Total Stockholder Equity
Retained Earnings 2,957,453
Total Stockholder Equity (as reported)3,737,968
Total Stockholder Equity (calculated)2,957,453
+/- 780,515
Other
Capital Stock431,054
Common Stock Shares Outstanding 431,054
Net Invested Capital 3,883,768
Net Working Capital 3,090,507
Property Plant and Equipment Gross 635,528



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302003-12-312002-12-312001-12-31
> Total Assets 
320,891
363,129
367,954
660,976
653,909
682,943
703,179
748,864
732,751
771,997
846,724
891,265
846,543
922,072
919,010
997,371
1,071,199
1,091,649
986,215
997,426
1,131,240
1,162,890
1,557,564
1,719,547
1,486,363
1,435,824
1,499,801
1,467,132
1,491,662
1,448,909
1,500,439
1,511,121
1,582,292
1,657,623
1,778,951
2,001,260
2,033,459
1,842,874
2,061,268
1,982,381
2,036,567
2,027,473
2,087,142
2,097,458
2,189,120
2,185,650
2,223,359
2,248,875
2,282,418
2,409,867
2,464,222
2,546,009
2,541,024
2,496,727
2,439,043
2,576,157
2,630,339
2,753,955
2,793,076
2,798,572
2,847,771
2,926,538
3,042,097
3,192,672
3,308,705
3,285,443
3,443,782
3,546,974
3,809,766
3,866,460
4,000,994
4,059,957
4,146,479
4,126,921
4,288,232
4,328,470
4,900,548
5,057,616
5,044,017
5,108,142
5,010,364
4,829,524
4,829,5245,010,3645,108,1425,044,0175,057,6164,900,5484,328,4704,288,2324,126,9214,146,4794,059,9574,000,9943,866,4603,809,7663,546,9743,443,7823,285,4433,308,7053,192,6723,042,0972,926,5382,847,7712,798,5722,793,0762,753,9552,630,3392,576,1572,439,0432,496,7272,541,0242,546,0092,464,2222,409,8672,282,4182,248,8752,223,3592,185,6502,189,1202,097,4582,087,1422,027,4732,036,5671,982,3812,061,2681,842,8742,033,4592,001,2601,778,9511,657,6231,582,2921,511,1211,500,4391,448,9091,491,6621,467,1321,499,8011,435,8241,486,3631,719,5471,557,5641,162,8901,131,240997,426986,2151,091,6491,071,199997,371919,010922,072846,543891,265846,724771,997732,751748,864703,179682,943653,909660,976367,954363,129320,891
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,133,219
2,181,248
2,266,616
2,386,686
2,527,788
2,637,665
2,642,571
2,825,714
2,932,313
3,134,529
3,111,313
3,188,185
3,315,789
3,390,968
3,361,188
3,482,786
3,546,706
4,041,357
4,225,744
4,185,365
4,236,887
4,120,694
3,771,578
3,771,5784,120,6944,236,8874,185,3654,225,7444,041,3573,546,7063,482,7863,361,1883,390,9683,315,7893,188,1853,111,3133,134,5292,932,3132,825,7142,642,5712,637,6652,527,7882,386,6862,266,6162,181,2482,133,21900000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
815,605
930,968
1,106,071
1,154,029
1,376,067
899,284
1,540,426
1,408,505
1,563,649
1,575,671
2,073,002
1,252,846
1,909,594
1,449,492
2,430,563
1,841,143
2,285,312
2,057,620
2,493,582
2,208,993
2,075,235
2,000,276
2,988,096
2,988,0962,000,2762,075,2352,208,9932,493,5822,057,6202,285,3121,841,1432,430,5631,449,4921,909,5941,252,8462,073,0021,575,6711,563,6491,408,5051,540,426899,2841,376,0671,154,0291,106,071930,968815,60500000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
352,927
0
285,360
98,246
71,968
83,815
94,317
336,723
293,456
388,401
36,318
564,490
95,238
611,207
106,023
485,683
40,799
888,818
674,349
798,131
901,826
854,555
63,285
63,285854,555901,826798,131674,349888,81840,799485,683106,023611,20795,238564,49036,318388,401293,456336,72394,31783,81571,96898,246285,3600352,92700000000000000000000000000000000000000000000000000000000000
       Net Receivables 
52,968
57,219
62,066
74,118
66,735
80,293
81,643
95,926
72,547
114,346
118,965
137,782
116,914
147,092
150,507
154,791
158,825
170,794
188,507
157,380
205,381
190,234
202,016
198,928
182,674
154,669
212,078
229,848
215,112
206,526
277,351
305,988
321,632
326,899
433,199
417,313
426,807
401,818
540,525
524,664
508,946
493,388
571,375
578,601
595,206
575,405
602,446
553,129
599,069
554,447
619,843
667,264
580,785
549,100
508,179
516,462
458,757
433,319
565,142
592,000
486,614
520,587
82,897
124,514
131,717
413,240
437,796
394,593
436,313
401,409
577,755
637,215
444,715
267,815
602,267
617,264
480,497
454,623
353,335
632,011
505,801
246,373
246,373505,801632,011353,335454,623480,497617,264602,267267,815444,715637,215577,755401,409436,313394,593437,796413,240131,717124,51482,897520,587486,614592,000565,142433,319458,757516,462508,179549,100580,785667,264619,843554,447599,069553,129602,446575,405595,206578,601571,375493,388508,946524,664540,525401,818426,807417,313433,199326,899321,632305,988277,351206,526215,112229,848212,078154,669182,674198,928202,016190,234205,381157,380188,507170,794158,825154,791150,507147,092116,914137,782118,965114,34672,54795,92681,64380,29366,73574,11862,06657,21952,968
       Other Current Assets 
3,698
3,108
4,160
4,163
3,591
6,427
5,090
11,532
9,202
5,707
11,073
3,638
7,156
9,714
12,525
27,882
28,044
16,649
6,038
4,245
2,948
35,176
15,311
12,024
9,987
30,825
25,116
22,925
17,139
37,905
28,710
21,989
22,623
38,276
37,457
39,399
39,120
42,137
35,944
45,177
60,837
72,203
50,305
40,735
41,680
48,599
91,352
47,437
335,389
50,895
386,680
57,429
437,832
55,034
451,968
60,594
510,637
58,138
454,103
53,355
443,187
44,554
289,501
87,848
585,231
62,811
321,894
92,825
401,178
117,053
507,870
95,058
588,625
100,851
278,241
132,166
275,772
128,177
144,956
91,899
223,456
33,140
33,140223,45691,899144,956128,177275,772132,166278,241100,851588,62595,058507,870117,053401,17892,825321,89462,811585,23187,848289,50144,554443,18753,355454,10358,138510,63760,594451,96855,034437,83257,429386,68050,895335,38947,43791,35248,59941,68040,73550,30572,20360,83745,17735,94442,13739,12039,39937,45738,27622,62321,98928,71037,90517,13922,92525,11630,8259,98712,02415,31135,1762,9484,2456,03816,64928,04427,88212,5259,7147,1563,63811,0735,7079,20211,5325,0906,4273,5914,1634,1603,1083,698
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
655,411
664,884
671,040
642,873
618,068
614,662
675,238
755,147
812,809
744,168
755,512
765,732
805,446
781,764
859,190
831,872
858,652
871,256
889,671
1,057,945
1,057,945889,671871,256858,652831,872859,190781,764805,446765,732755,512744,168812,809755,147675,238614,662618,068642,873671,040664,884655,41100000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
126,001
120,233
124,377
128,980
129,856
136,591
139,527
142,931
156,128
150,707
183,146
198,976
183,707
198,050
179,640
201,386
200,374
242,935
169,079
196,533
195,999
237,107
218,165
248,743
222,099
251,982
236,616
264,109
236,289
265,443
238,277
266,140
240,508
277,045
253,052
278,201
250,480
239,255
231,317
239,280
236,072
284,236
259,404
251,396
287,091
307,748
343,791
361,646
370,954
407,426
403,395
402,383
397,791
386,614
360,931
354,769
350,208
345,089
338,285
332,394
327,238
323,754
317,558
315,472
311,057
309,191
302,459
301,245
333,443
344,056
431,258
418,261
429,897
440,440
429,391
423,621
502,368
515,343
513,102
523,536
542,452
635,528
635,528542,452523,536513,102515,343502,368423,621429,391440,440429,897418,261431,258344,056333,443301,245302,459309,191311,057315,472317,558323,754327,238332,394338,285345,089350,208354,769360,931386,614397,791402,383403,395407,426370,954361,646343,791307,748287,091251,396259,404284,236236,072239,280231,317239,255250,480278,201253,052277,045240,508266,140238,277265,443236,289264,109236,616251,982222,099248,743218,165237,107195,999196,533169,079242,935200,374201,386179,640198,050183,707198,976183,146150,707156,128142,931139,527136,591129,856128,980124,377120,233126,001
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,847
15,847
15,847
23,903
23,884
23,884
23,884
22,965
22,965
22,965
22,965
21,958
18,542
18,542
18,542
18,828
18,828
18,828
18,828
14,848
14,848
14,848
14,848
6,232
6,232
6,899
22,475
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,263
25,26325,26325,26325,26325,26325,26325,26325,26325,26325,26325,26325,26325,26322,4756,8996,2326,23214,84814,84814,84814,84818,82818,82818,82818,82818,54218,54218,54221,95822,96522,96522,96522,96523,88423,88423,88423,90315,84715,84715,847000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204,504
206,839
206,607
214,963
220,138
222,915
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000222,915220,138214,963206,607206,839204,50400000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
2,902
3,648
3,417
3,289
3,075
2,755
2,658
148
2,749
4,493
17,330
3,995
17,019
3,488
27,151
3,137
32,063
2,802
32,836
2,770
39,610
3,116
40,879
2,776
40,472
2,818
40,890
2,636
41,238
5,824
43,888
5,386
48,125
5,162
48,717
5,122
49,459
9,423
39,948
8,930
39,893
8,707
34,141
34,017
34,121
41,539
40,910
40,635
40,467
39,134
38,907
38,843
38,765
38,794
32,316
32,560
32,297
33,087
33,210
13,908
13,831
13,496
39,037
35,798
42,385
43,438
42,841
43,548
54,577
62,279
62,045
63,818
64,715
67,201
69,511
71,752
75,035
80,196
85,441
88,860
92,349
161,774
161,77492,34988,86085,44180,19675,03571,75269,51167,20164,71563,81862,04562,27954,57743,54842,84143,43842,38535,79839,03713,49613,83113,90833,21033,08732,29732,56032,31638,79438,76538,84338,90739,13440,46740,63540,91041,53934,12134,01734,1418,70739,8938,93039,9489,42349,4595,12248,7175,16248,1255,38643,8885,82441,2382,63640,8902,81840,4722,77640,8793,11639,6102,77032,8362,80232,0633,13727,1513,48817,0193,99517,3304,4932,7491482,6582,7553,0753,2893,4173,6482,902
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,385
10,385
10,385
37,040
511
36,473
333,443
43,235
42,945
2,204
1,871
6,268
14,650
9,157
9,700
8,144
12,610
14,115
12,975
22,459
22,45912,97514,11512,6108,1449,7009,15714,6506,2681,8712,20442,94543,235333,44336,47351137,04010,38510,38510,38500000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
148,880
158,590
136,605
125,141
109,387
130,741
120,981
166,897
141,194
175,451
196,689
249,181
192,764
250,530
190,638
209,115
225,802
238,532
203,286
195,361
277,572
291,465
627,760
748,123
463,316
384,107
385,901
366,347
370,352
321,682
317,083
285,157
325,456
337,696
395,367
607,090
610,353
409,565
559,335
487,937
501,894
461,215
462,013
469,399
514,602
486,889
478,397
437,441
431,313
523,312
499,886
590,339
545,113
479,876
352,342
437,811
439,931
482,987
459,355
527,176
549,621
574,674
554,866
685,068
729,999
650,487
704,865
800,357
958,345
919,893
937,023
920,023
903,626
812,721
834,796
906,855
1,338,571
1,438,755
1,286,651
1,392,168
1,166,024
959,618
959,6181,166,0241,392,1681,286,6511,438,7551,338,571906,855834,796812,721903,626920,023937,023919,893958,345800,357704,865650,487729,999685,068554,866574,674549,621527,176459,355482,987439,931437,811352,342479,876545,113590,339499,886523,312431,313437,441478,397486,889514,602469,399462,013461,215501,894487,937559,335409,565610,353607,090395,367337,696325,456285,157317,083321,682370,352366,347385,901384,107463,316748,123627,760291,465277,572195,361203,286238,532225,802209,115190,638250,530192,764249,181196,689175,451141,194166,897120,981130,741109,387125,141136,605158,590148,880
   > Total Current Liabilities 
148,680
157,340
130,006
118,241
107,487
129,141
119,381
165,197
138,895
161,011
181,969
233,962
188,052
241,492
174,238
206,714
222,757
236,821
201,653
194,183
276,394
287,866
622,593
744,697
460,193
382,905
385,041
365,761
369,321
321,389
316,622
284,863
325,163
331,796
389,467
601,190
604,453
405,025
554,795
484,402
499,049
456,935
457,733
460,747
506,254
475,997
466,473
424,022
418,241
505,941
480,487
575,691
528,704
414,639
288,070
375,341
370,315
365,262
349,084
420,340
439,885
462,477
442,765
567,954
613,680
538,447
593,507
689,642
846,850
801,432
753,561
799,720
761,380
665,440
705,340
786,566
755,296
858,139
666,079
788,147
565,375
681,071
681,071565,375788,147666,079858,139755,296786,566705,340665,440761,380799,720753,561801,432846,850689,642593,507538,447613,680567,954442,765462,477439,885420,340349,084365,262370,315375,341288,070414,639528,704575,691480,487505,941418,241424,022466,473475,997506,254460,747457,733456,935499,049484,402554,795405,025604,453601,190389,467331,796325,163284,863316,622321,389369,321365,761385,041382,905460,193744,697622,593287,866276,394194,183201,653236,821222,757206,714174,238241,492188,052233,962181,969161,011138,895165,197119,381129,141107,487118,241130,006157,340148,680
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,300
28,800
36,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000036,80028,80027,30000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,300
28,800
36,800
38,000
33,000
142,500
152,500
133,000
133,000
82,000
91,000
88,000
88,200
38,000
88,100
88,100
53,000
53,000
36,000
45,800
45,80036,00053,00053,00088,10088,10038,00088,20088,00091,00082,000133,000133,000152,500142,50033,00038,00036,80028,80027,30000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
18,301
22,752
32,352
35,307
32,474
35,674
33,287
38,185
36,212
45,490
78,955
85,466
90,167
80,316
86,239
78,477
82,936
96,641
104,301
92,214
144,745
130,327
190,548
216,473
198,564
198,644
223,925
197,756
196,345
166,530
171,600
162,348
149,383
122,463
191,746
387,365
371,561
176,533
326,570
194,156
227,851
187,715
185,095
164,169
230,149
196,951
195,742
170,740
187,502
225,556
237,715
227,177
205,467
140,052
121,252
90,495
95,088
81,033
95,087
68,794
97,880
77,775
135,877
176,221
184,233
113,062
260,351
104,395
161,188
152,314
230,877
180,368
146,297
156,824
265,287
208,892
249,335
284,737
286,008
289,183
209,681
289,686
289,686209,681289,183286,008284,737249,335208,892265,287156,824146,297180,368230,877152,314161,188104,395260,351113,062184,233176,221135,87777,77597,88068,79495,08781,03395,08890,495121,252140,052205,467227,177237,715225,556187,502170,740195,742196,951230,149164,169185,095187,715227,851194,156326,570176,533371,561387,365191,746122,463149,383162,348171,600166,530196,345197,756223,925198,644198,564216,473190,548130,327144,74592,214104,30196,64182,93678,47786,23980,31690,16785,46678,95545,49036,21238,18533,28735,67432,47435,30732,35222,75218,301
       Other Current Liabilities 
47,379
50,688
61,086
62,784
55,013
73,467
58,094
99,012
74,683
87,521
78,014
125,496
74,885
138,176
74,999
86,673
95,360
118,180
87,352
87,969
69,219
112,039
96,765
103,244
121,649
123,271
115,220
121,508
109,143
104,022
93,736
75,015
124,180
159,583
151,521
171,125
189,402
185,002
190,725
246,746
202,698
229,220
232,638
253,577
221,605
211,546
166,331
163,881
147,238
199,885
162,271
267,014
241,738
184,087
157,818
276,847
267,226
270,229
239,997
267,660
321,237
186,180
273,501
235,436
387,583
227,516
289,579
370,203
526,207
325,166
382,579
421,140
508,540
225,716
324,158
407,808
384,673
338,668
19,985
339,172
14,143
20,225
20,22514,143339,17219,985338,668384,673407,808324,158225,716508,540421,140382,579325,166526,207370,203289,579227,516387,583235,436273,501186,180321,237267,660239,997270,229267,226276,847157,818184,087241,738267,014162,271199,885147,238163,881166,331211,546221,605253,577232,638229,220202,698246,746190,725185,002189,402171,125151,521159,583124,18075,01593,736104,022109,143121,508115,220123,271121,649103,24496,765112,03969,21987,96987,352118,18095,36086,67374,999138,17674,885125,49678,01487,52174,68399,01258,09473,46755,01362,78461,08650,68847,379
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
112,101
117,113
116,319
112,040
111,358
110,714
111,495
118,461
183,462
120,302
142,247
147,281
129,457
120,289
583,275
580,616
620,571
604,020
600,649
278,547
278,547600,649604,020620,571580,616583,275120,289129,457147,281142,247120,302183,462118,461111,495110,714111,358112,040116,319117,113112,10100000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-27,300
-28,800
-36,800
0
0
0
0
0
65,124
65,124
84,659
73,208
71,777
65,854
131,765
122,000
119,912
116,261
114,097
93,587
93,587114,097116,261119,912122,000131,76565,85471,77773,20884,65965,12465,12400000-36,800-28,800-27,30000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,839
91,064
88,789
86,484
86,709
86,934
88,097
87,854
88,392
26,155
29,225
42,532
27,337
24,845
23,072
29,540
28,627
29,211
29,081
28,459
28,45929,08129,21128,62729,54023,07224,84527,33742,53229,22526,15588,39287,85488,09786,93486,70986,48488,78991,06490,83900000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,587
75,026
71,455
71,263
72,000
79,369
71,033
66,943
62,873
59,356
61,378
64,812
70,165
69,333
58,436
57,704
59,326
61,397
0
0
69,549
0
0
0069,5490061,39759,32657,70458,43669,33370,16564,81261,37859,35662,87366,94371,03379,36972,00071,26371,45575,02677,58700000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
148,045
178,311
204,847
508,900
518,282
528,275
542,988
542,128
552,178
569,295
583,660
575,090
587,615
421,011
644,093
670,422
712,593
718,553
729,739
748,580
768,819
780,576
836,443
874,698
927,006
951,438
1,003,436
987,038
1,009,049
1,023,046
1,079,414
1,117,800
1,149,924
1,153,286
1,218,456
1,229,880
1,262,157
1,290,611
1,361,012
1,355,948
1,398,236
1,425,885
1,498,299
1,500,187
1,549,501
1,570,438
1,644,309
1,703,342
1,747,807
1,784,102
1,864,136
1,855,406
1,904,112
1,940,276
2,026,730
2,052,938
2,112,071
2,192,173
2,259,510
2,197,262
2,216,065
2,270,737
2,408,850
2,429,481
2,495,122
2,556,926
2,666,612
2,673,690
2,766,280
2,849,405
2,959,173
2,966,037
3,066,754
3,171,382
3,308,829
3,291,503
3,435,121
3,496,241
3,644,301
3,587,772
3,718,575
3,737,968
3,737,9683,718,5753,587,7723,644,3013,496,2413,435,1213,291,5033,308,8293,171,3823,066,7542,966,0372,959,1732,849,4052,766,2802,673,6902,666,6122,556,9262,495,1222,429,4812,408,8502,270,7372,216,0652,197,2622,259,5102,192,1732,112,0712,052,9382,026,7301,940,2761,904,1121,855,4061,864,1361,784,1021,747,8071,703,3421,644,3091,570,4381,549,5011,500,1871,498,2991,425,8851,398,2361,355,9481,361,0121,290,6111,262,1571,229,8801,218,4561,153,2861,149,9241,117,8001,079,4141,023,0461,009,049987,0381,003,436951,438927,006874,698836,443780,576768,819748,580729,739718,553712,593670,422644,093421,011587,615575,090583,660569,295552,178542,128542,988528,275518,282508,900204,847178,311148,045
   Common Stock
33,800
33,170
33,170
51,170
51,170
51,170
51,170
51,170
51,170
51,170
51,170
51,170
51,170
51,170
51,170
61,404
61,404
61,404
61,404
92,106
92,106
92,106
92,106
165,790
165,790
165,790
165,790
165,790
165,790
165,790
165,790
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
331,580
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
431,054
0
0
431,054
0
0
00431,05400431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054431,054331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580331,580165,790165,790165,790165,790165,790165,790165,790165,79092,10692,10692,10692,10661,40461,40461,40461,40451,17051,17051,17051,17051,17051,17051,17051,17051,17051,17051,17051,17033,17033,17033,800
   Retained Earnings 
49,452
65,299
67,725
94,609
103,991
66,147
80,860
100,464
110,556
113,551
103,340
119,852
134,637
143,971
184,349
202,020
244,512
248,023
258,514
246,662
266,917
269,273
325,164
326,555
378,889
387,644
439,646
423,576
446,242
448,169
504,525
475,723
507,887
497,976
563,139
574,587
606,870
616,990
687,383
682,318
724,803
730,088
1,047,373
1,049,165
1,098,505
1,120,327
1,194,178
1,250,832
1,192,957
1,230,846
1,311,099
1,302,896
1,351,481
1,394,879
1,481,575
1,483,011
1,544,349
1,628,719
1,697,032
1,632,210
1,650,263
1,705,785
1,543,733
1,564,809
1,641,172
1,995,287
2,104,659
2,118,472
2,212,729
2,298,573
2,415,833
2,424,051
2,537,005
2,633,848
2,771,398
2,754,913
2,899,034
2,666,691
2,853,426
3,091,615
2,933,333
2,957,453
2,957,4532,933,3333,091,6152,853,4262,666,6912,899,0342,754,9132,771,3982,633,8482,537,0052,424,0512,415,8332,298,5732,212,7292,118,4722,104,6591,995,2871,641,1721,564,8091,543,7331,705,7851,650,2631,632,2101,697,0321,628,7191,544,3491,483,0111,481,5751,394,8791,351,4811,302,8961,311,0991,230,8461,192,9571,250,8321,194,1781,120,3271,098,5051,049,1651,047,373730,088724,803682,318687,383616,990606,870574,587563,139497,976507,887475,723504,525448,169446,242423,576439,646387,644378,889326,555325,164269,273266,917246,662258,514248,023244,512202,020184,349143,971134,637119,852103,340113,551110,556100,46480,86066,147103,99194,60967,72565,29949,452
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
744
1,495
1,293
6,164
5,719
5,650
2,547
2,861
2,834
2,271
1,665
1,721
1,513
1,528
1,283
1,180
1,868
2,636
2,462
0
2,900
0
0
002,90002,4622,6361,8681,1801,2831,5281,5131,7211,6652,2712,8342,8612,5475,6505,7196,1641,2931,49574400000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,136,746
Cost of Revenue-1,822,074
Gross Profit1,314,6721,314,672
 
Operating Income (+$)
Gross Profit1,314,672
Operating Expense-2,720,560
Operating Income416,186-1,405,888
 
Operating Expense (+$)
Research Development69,014
Selling General Administrative750,545
Selling And Marketing Expenses0
Operating Expense2,720,560819,560
 
Net Interest Income (+$)
Interest Income60,980
Interest Expense-16,854
Other Finance Cost-195
Net Interest Income44,321
 
Pretax Income (+$)
Operating Income416,186
Net Interest Income44,321
Other Non-Operating Income Expenses0
Income Before Tax (EBT)524,703416,186
EBIT - interestExpense = -16,854
443,251
460,105
Interest Expense16,854
Earnings Before Interest and Taxes (EBIT)0541,557
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax524,703
Tax Provision-72,864
Net Income From Continuing Ops451,839451,839
Net Income443,251
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-44,321
 

Technical Analysis of Mayinglong
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mayinglong. The general trend of Mayinglong is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mayinglong's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mayinglong Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 26.23 < 26.35 < 27.16.

The bearish price targets are: 25.29 > 24.55 > 24.20.

Tweet this
Mayinglong Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mayinglong Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mayinglong Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mayinglong Pharmaceutical Group Co Ltd. The current macd is 0.74522352.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mayinglong price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Mayinglong. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Mayinglong price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mayinglong Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMayinglong Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mayinglong Pharmaceutical Group Co Ltd. The current adx is 33.21.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Mayinglong shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Mayinglong Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mayinglong Pharmaceutical Group Co Ltd. The current sar is 23.68.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Mayinglong Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mayinglong Pharmaceutical Group Co Ltd. The current rsi is 74.99. The current phase is Overbought in neutral market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Overbought in neutral market:
  • Trending up: The RSI is trending up. +1
Mayinglong Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartMayinglong Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mayinglong Pharmaceutical Group Co Ltd. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mayinglong price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Mayinglong Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartMayinglong Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mayinglong Pharmaceutical Group Co Ltd. The current cci is 127.35.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Mayinglong Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartMayinglong Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mayinglong Pharmaceutical Group Co Ltd. The current cmo is 64.28.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Mayinglong Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartMayinglong Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mayinglong Pharmaceutical Group Co Ltd. The current willr is -10.68376068.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Mayinglong Pharmaceutical Group Co Ltd Daily Williams %R ChartMayinglong Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mayinglong Pharmaceutical Group Co Ltd.

Mayinglong Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mayinglong Pharmaceutical Group Co Ltd. The current atr is 0.76681472.

Mayinglong Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartMayinglong Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mayinglong Pharmaceutical Group Co Ltd. The current obv is 171,870,498.

Mayinglong Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartMayinglong Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mayinglong Pharmaceutical Group Co Ltd. The current mfi is 99.08.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Mayinglong Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartMayinglong Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mayinglong Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Mayinglong Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mayinglong Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5074.995
Ma 20Greater thanMa 5023.599
Ma 50Greater thanMa 10023.248
Ma 100Greater thanMa 20023.606
OpenGreater thanClose25.630
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Mayinglong with someone you think should read this too:
  • Are you bullish or bearish on Mayinglong? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mayinglong? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mayinglong Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Mayinglong Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Mayinglong Pharmaceutical Group Co Ltd.

Receive notifications about Mayinglong Pharmaceutical Group Co Ltd in your mailbox!